Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -5.25 | 24.15 |
PEG Ratio (TTM) | -0.28 | 2.51 |
P/S Ratio (TTM) | 6.71 | 5.36 |
P/B Ratio (TTM) | 2.28 | 4.93 |
P/FCF Ratio (TTM) | -12.87 | 11.02 |
Price to 5YR AVG Earnings Ratio | N/A | 4.70 |
Price to 5YR AVG FCF Ratio | N/A | 23.65 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -29.71% | 3.15% |
ROE (TTM) | -38.94% | 32.00% |
Net Profit Margin (TTM) | -98.08% | -10.34% |
ROIC 5YR AVG | N/A | 10.79% |
Growth (22%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 11.40% | -117.62% | N/A |
Revenue | -2.81% | 28.64% | N/A |
Net Income | 2.72% | -128.42% | N/A |
Cash Flow | -12.20% | -216.28% | N/A |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.76 | 2.48 |
Quick Ratio (TTM) | 3.28 | 1.83 |
D/E Ratio (TTM) | 0.19 | 0.01 |
Interest Coverage (TTM) | 38.07 | 12.14 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | 2.17 | 4.69 |
LTL to 5YR AVG FCF | N/A | 4.72 |
Shares Outstanding Growth 5YR AVG | N/A | 29.02% |